A.J. Day Takes the Helm at Wilcrest Pharma
Wilcrest Pharma, located in Houston and dedicated to producing essential medications, has named A.J. Day, PharmD, as its new chief executive officer. This forward-thinking 503B outsourcing facility is focused on meeting the urgent need for antineoplastic drugs, directly addressing the critical drug shortages that challenge healthcare systems.
Company Mission and Vision
Wilcrest Pharma is committed to improving patient healthcare by ensuring the availability of medications that are often in limited supply. This includes both sterile and nonsterile medications essential for clinics, pharmacies, and health systems. A.J. Day highlights that the company combines clinical and technical knowledge with CGMP practices. “We are dedicated to providing quality products that meet patient needs, ensuring medications are delivered on time,” he stated.
A.J. Day’s Background and Experience
Prior to his role at Wilcrest Pharma, Day served as the vice president of Clinical Services at PCCA, a leading provider of pharmaceutical chemicals and equipment. His extensive background encompasses regulatory affairs and the compounding supply chain, skills that will be crucial as Wilcrest Pharma embarks on its growth journey. Day has a solid history of advocating for compounded medicine, having provided expert testimony to the U.S. FDA and contributed to various pharmacy committees.
Commitment to Education and Advocacy
Throughout his career, Day has been an influential figure in educational programs for healthcare professionals. He has written numerous journal articles and led continuing education initiatives for pharmacists, veterinarians, and physicians around the globe, showcasing his commitment to advancing the pharmacy profession.
Continuing a Legacy of Involvement
Day's influence extends beyond his previous positions, as he actively participates in several pharmacy organizations, including the American Society of Health-System Pharmacists and the Society of Veterinary Hospital Pharmacists. He holds a Doctor of Pharmacy degree from the University of Houston and has also studied chemistry at the University of Texas at Austin.
About Wilcrest Pharma
Wilcrest Pharma is dedicated to addressing unmet pharmaceutical needs by providing high-quality antineoplastic medications. The company is preparing for its official launch after successfully completing FDA registration and passing necessary inspections. Their operations will be vital in mitigating drug shortages and enhancing medication delivery within the healthcare sector.
Media Contact Information
Media contact: Briana Herrington, Burson
Frequently Asked Questions
What is the role of A.J. Day at Wilcrest Pharma?
A.J. Day serves as the CEO of Wilcrest Pharma, overseeing its operations and strategic initiatives aimed at addressing drug shortages.
What are antineoplastic drugs?
Antineoplastic drugs are medications designed to treat cancer by inhibiting the growth of tumor cells.
What is a 503B outsourcing facility?
A 503B outsourcing facility is a type of compounding pharmacy that produces medications for office use while adhering to specific FDA regulations.
What is Wilcrest Pharma's mission?
Wilcrest Pharma's mission is to deliver high-quality medications and tackle shortages within the healthcare system to enhance patient care.
How can I get in touch with Wilcrest Pharma?
For media inquiries, you can reach out to Briana Herrington at Burson for more information about the company.
